- FDA approves pancreatic cancer drug that extends patients’ lives The Washington Post
- F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer The New York Times
- FDA approves once-daily pill for deadly cancer after patients’ survival rates nearly double Fox News
- A Breakthrough Pancreatic Cancer Drug Marks a New Era for Treatment Bloomberg
- Stage 4 Maine cancer patient says new FDA-approved pill is buying him time WGME
Source: Google Finance – Market News